Literature DB >> 8647203

Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity.

A Poggi1, P Costa, L Morelli, C Cantoni, N Pella, F Spada, R Biassoni, L Nanni, V Revello, E Tomasello, M C Mingari, A Moretta, L Moretta.   

Abstract

In this study, we show that NKRP1A is expressed and functions on a subset of immature human thymocytes. We took advantage of the monoclonal antibody (mAb) 191B8 that was obtained by immunizing mice with cultured human thymocytes characterized by an immature surface phenotype [CD2- CD3- CD4- CD8- stem cell factor receptor (SCFR)+] and expressing cytoplasmic CD3 epsilon chain. The 191B8 antibody homogeneously reacted with the immunizing population but not with most unfractionated thymocytes. It stained a minor population of resting immature thymocytes co-expressing CD34, SCFR, or both. Following culture of the CD34+ or CD34- fractions of CD2- CD3- CD4- CD8- purified immature thymocytes with recombinant interleukin-2 (rIL-2), the 191B8-defined antigen was expressed on virtually all cells even when 191B8+ cells were removed from the starting population. On the other hand, no 191B8+ cells were detected in fresh or cultured thymocytes expressing a more mature phenotype. Biochemical analysis of 191B8 mAb-reactive molecules revealed, under non-reducing conditions, two bands displaying apparent molecular masses of 80 and 44 kDa and a single band of 44 kDa under reducing conditions. Digestion with proteases indicated that the 80-kDa form represented a homodimeric form of two 44-kDa molecules, while deglycosylation with N-glycanase suggested the existence of four N-glycosylation sites. Transfection of COS7 or NIH3T3 cells with hNKRP1A cDNA showed that the 191B8 mAb recognized NKRP1A as shown by both immunofluorescence analysis and immunoprecipitation experiments. Functional studies showed that the 191B8/NKRP1A molecule mediated strong inhibition of the cytolytic activity of cultured CD2- CD3- immature thymocytes against a panel of tumor target cells. More importantly, 191B8 mAb induced proliferation of CD2- CD3- fresh thymocytes which was not increased by rIL-2. Thus, we propose that NKRP1A molecules, which are expressed in highly immature thymocytes, may play a regulatory role in their growth and function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8647203     DOI: 10.1002/eji.1830260613

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  On the cell biology of pit cells, the liver-specific NK cells.

Authors:  Dian-Zhong Luo; David Vermijlen; Bulent Ahishali; Vasilis Triantis; Georgia Plakoutsi; Filip Braet; Karin Vanderkerken; Eddie Wisse
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.

Authors:  A Nicol; M Nieda; Y Koezuka; S Porcelli; K Suzuki; K Tadokoro; S Durrant; T Juji
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

3.  Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.

Authors:  David B Rosen; Wei Cao; Danielle T Avery; Stuart G Tangye; Yong-Jun Liu; J P Houchins; Lewis L Lanier
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 4.  C-type lectins, fungi and Th17 responses.

Authors:  Simon Vautier; Maria da Glória Sousa; Gordon D Brown
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-12       Impact factor: 7.638

5.  Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes.

Authors:  J R Carlyle; A M Michie; C Furlonger; T Nakano; M J Lenardo; C J Paige; J C Zúñiga-Pflücker
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

6.  Regulation of the transcriptional program by DNA methylation during human αβ T-cell development.

Authors:  Ramon M Rodriguez; Beatriz Suarez-Alvarez; David Mosén-Ansorena; Marina García-Peydró; Patricia Fuentes; María J García-León; Aintzane Gonzalez-Lahera; Nuria Macias-Camara; María L Toribio; Ana M Aransay; Carlos Lopez-Larrea
Journal:  Nucleic Acids Res       Date:  2014-12-24       Impact factor: 16.971

7.  Respiratory syncytial virus infection, TLR3 ligands, and proinflammatory cytokines induce CD161 ligand LLT1 expression on the respiratory epithelium.

Authors:  Stifani Satkunanathan; Naveenta Kumar; Monika Bajorek; Marco A Purbhoo; Fiona J Culley
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 8.  Human Gut-Associated Natural Killer Cells in Health and Disease.

Authors:  Alessandro Poggi; Roberto Benelli; Roberta Venè; Delfina Costa; Nicoletta Ferrari; Francesca Tosetti; Maria Raffaella Zocchi
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

Review 9.  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.

Authors:  Alessandro Poggi; Maria Raffaella Zocchi
Journal:  Mol Ther Oncolytics       Date:  2021-11-29       Impact factor: 7.200

Review 10.  Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems.

Authors:  Christina L Kirkham; James R Carlyle
Journal:  Front Immunol       Date:  2014-06-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.